After reviewing the medical histories of (6052) women with BRCA1 or BRCA2 mutation, half of them developed breast cancer (especially TNBC) and faced a twofold increase risk of diabetes in the 15 years after breast cancer diagnosis [69]. This evidence concerns the gene BRCA2 and breast carcinoma.